健康大视野·医学分册2023,Issue(7) :75-76,79.DOI:10.3969/j.issn.1005-0019.2023.07.035

谷氨酰胺联合乌司他丁治疗脓毒症患者的临床疗效

褚波 朱善香
健康大视野·医学分册2023,Issue(7) :75-76,79.DOI:10.3969/j.issn.1005-0019.2023.07.035

谷氨酰胺联合乌司他丁治疗脓毒症患者的临床疗效

褚波 1朱善香2
扫码查看

作者信息

  • 1. 青岛大学附属泰安市中心医院,山东 泰安 271000
  • 2. 青岛大学附属泰安市中心医院碧霞湖院区,山东 泰安 271000
  • 折叠

摘要

目的:探究脓毒症患者应用谷氨酰胺联合乌司他丁效果.方法:选取2020年12月-2021年12月收治的180位脓毒症患者,分成研究组与参照组各90位.参照组采取乌司他丁,研究组在参照组的基础上加用丙氨酰谷氨酰胺.比较两组患者的治疗效果,恢复情况、免疫与炎症因子水平.结果:研究组治疗总有效率为84.44%,高于参照组的70.00%(P < 0.05).治疗后,APACHE Ⅱ评分研究组低于参照组;机械通气和住院时间研究组低于参照组;治疗后,两组的IL-6与TNF-α水平均比治疗前有所降低,IgA以及IgG水平

Abstract

Objective To explore the effect of glutamine combined with ulastatin in patients with sepsis. Methods: 180 sepsis patients admitted from December 2020 to December 2021 were selected and divided into 90 patients from the study group and the reference group. The reference group adopted ulinastatin, and the study group added alanine-glutamine to the reference group. Comparing the two groups, recovery, immunity and levels of inflammatory factors. Results: The overall response rate in the study group was 84.44%, which was higher than 70.00% in the reference group (P <0.05). After treatment, the APACHE Ⅱ score was lower than the reference group; mechanical ventilation and length of stay were lower than the reference group; IL-6 and TNF- α levels in both groups decreased than before treatment, and IgA and IgG levels increased than before treatment (P<0.05). Conclusion: Glutamine and ulinastatin can improve the efficacy and immune function of patients, improve the body circulation, and accelerate the recovery of patients, which is worth promoting.

关键词

脓毒症/乌司他丁/谷氨酰胺/炎症因子

Key words

Sepsis/ulinastatin/glutamine/inflammatory factors

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量17
段落导航相关论文